GEHC launches AI-enhanced ultrasound and ECG-less Cardiac CT technologies, offering rapid, accurate cardiac diagnostics at the point of care.
GE HealthCare's (GEHC) latest collaboration is likely to equip clinicians with a toolset to deliver enhanced care to female patients and improve the patient experience.
GE HealthCare's Q2 earnings were disappointing, with revenue stagnating and cost efficiencies driving earnings, leading to a lowered price target and sell rating. The company continues to lag behind the market in various healthcare sectors, with AI potential diminishing and a decreased focus on R&D. Upside potential lies in the healthcare market and AI technology, but GEHC's slow progress and competition pose challenges for future growth.
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
GE HealthCare's (GEHC) second-quarter results witness declining segmental revenues in imaging, ultrasound and patient care. The bottom line improves on better pricing.
GE HealthCare (GEHC) shares rose over 4% in early trading Wednesday after the company reported second-quarter profits that beat analysts' estimates.
While the top- and bottom-line numbers for GE HealthCare (GEHC) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
GE HealthCare Technologies (GEHC) came out with quarterly earnings of $1 per share, beating the Zacks Consensus Estimate of $0.98 per share. This compares to earnings of $0.92 per share a year ago.
GE HealthCare posts adjusted earnings per share of $1 in the second quarter, higher than estimates of 98 cents.
Shares of GE Healthcare Technologies Inc. GEHC tumbled 9.3% in premarket trading Wednesday, after the medical technologies and diagnostics company reported second-quarter revenue that missed expectations and cash flow that was more negative. Net income rose to $428 million, or 93 cents a share, from $418 million, or 91 cents a share, in the same period a year ago.
GE HealthCare's (GEHC) second-quarter results are likely to witness declining segmental revenues in imaging, ultrasound and patient care. The bottom-line results may reflect better pricing.
After taking a backseat in the first half, the healthcare sector is finally coming to life. The rising odds of a Trump presidency have improved prospects for the industry, validating the case for increasing positions in healthcare stocks to buy now.